tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Longeveron Inc. (LGVN)
:LGVN
US Market
LGVN
Longeveron
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Longeveron (LGVN) Stock News & Sentiment

Compare
554 Followers
Longeveron Gains FDA Approval for Laromestrocel Trial
Premium
Company Announcements
Longeveron Gains FDA Approval for Laromestrocel Trial
17d ago
8K
LGVN
Longeveron Receives Buy Rating: Promising Pipeline and Strategic Expansion into Pediatric Cardiomyopathy
Premium
Ratings
Longeveron Receives Buy Rating: Promising Pipeline and Strategic Expansion into Pediatric Cardiomyopathy
18d ago
LGVN
Positive Buy Rating for Longeveron Driven by Phase 2b Study Milestone and Favorable Market Conditions
Premium
Ratings
Positive Buy Rating for Longeveron Driven by Phase 2b Study Milestone and Favorable Market Conditions
1M ago
LGVN
Longeveron Elects New Director at Annual Meeting
Premium
Company Announcements
Longeveron Elects New Director at Annual Meeting
1M ago
8K
LGVN
Buy Rating for Longeveron: ELPIS II Trial Progress and Financial Stability Highlighted
Premium
Ratings
Buy Rating for Longeveron: ELPIS II Trial Progress and Financial Stability Highlighted
2M ago
LGVN
Longeveron: Strategic Advancements and Promising Developments Drive Buy Rating
Premium
Ratings
Longeveron: Strategic Advancements and Promising Developments Drive Buy Rating
2M ago
LGVN
Longeveron Reports Q1 2025 Progress and Financials
Premium
Company Announcements
Longeveron Reports Q1 2025 Progress and Financials
3M ago
LGVN
More LGVN News >

LGVN News on the Web

Roth MKM Remains a Buy on Longeveron (LGVN)
TipRanks News
Neutral
Longeveron (LGVN) Receives a Buy from Roth MKM
TipRanks News
Neutral
Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel in Alzheimer’s Disease
Yahoo Finance
Neutral
Longeveron® to Present at the 37th Annual Roth Conference
Yahoo Finance
Neutral
Analysts Expect Breakeven For Longeveron Inc. Before Long
Yahoo Finance
Neutral
Longeveron Full Year 2024 Earnings: Beats Expectations
Yahoo Finance
Neutral
Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update
Yahoo Finance
Neutral
Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
LGVN
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average57%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is LGVN’s Media Buzz Sentiment?
Currently, no data Available
What is LGVN’s weekly average amount of articles?
Currently, no data Available
What is LGVN’s News Sentiment?
59% of articles about LGVN were positive this week, compared to its sector average of 57%.
    Healthcare Stocks that are Trending in the News
    WSTWest Pharmaceutical Services
    NVSTEnvista Holdings
    MTDMettler-Toledo
    GMABGenmab
    LHLabcorp Holdings
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing